Cargando…
Human stem cell derived beta-like cells engineered to present PD-L1 improve transplant survival in NOD mice carrying human HLA class I
There is a critical need for therapeutic approaches that combine renewable sources of replacement beta cells with localized immunomodulation to counter recurrence of autoimmunity in type 1 diabetes (T1D). However, there are few examples of animal models to study such approaches that incorporate spon...
Autores principales: | Santini-González, Jorge, Castro-Gutierrez, Roberto, Becker, Matthew W., Rancourt, Chad, Russ, Holger A., Phelps, Edward A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732725/ https://www.ncbi.nlm.nih.gov/pubmed/36506044 http://dx.doi.org/10.3389/fendo.2022.989815 |
Ejemplares similares
-
Protecting Stem Cell Derived Pancreatic Beta-Like Cells From Diabetogenic T Cell Recognition
por: Castro-Gutierrez, Roberto, et al.
Publicado: (2021) -
Expression of HLA Class II Molecules in Humanized NOD.Rag1KO.IL2RgcKO Mice Is Critical for Development and Function of Human T and B Cells
por: Danner, Rebecca, et al.
Publicado: (2011) -
Human Beta Cell Regenerative Drug Therapy for Diabetes: Past Achievements and Future Challenges
por: Wang, Peng, et al.
Publicado: (2021) -
Utilization of commercial collagens for preparing well-differentiated human beta cells for confocal microscopy
por: Brennecke, Brianna R., et al.
Publicado: (2023) -
In vitro beta-cell killing models using immune cells and human pluripotent stem cell-derived islets: Challenges and opportunities
por: Halliez, Clémentine, et al.
Publicado: (2023)